Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth G Linden

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
JAAD Case Reports|October 21, 2024
Relapsing toxic epidermal necrolysis following COVID-19Feben Messele, Luke Horton, Ajay N Sharma, et al.
International Journal of Dermatology|February 21, 2022
Yellow urticaria: a rare phenomenonSamuel A Stetkevich, Brittany Urso, Lina Saeed, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 28, 2010
Medical students educate teens about skin cancer: what have we learned?Jeanette M Kamell, William Rietkerk, Ken Lam, et al.
The Journal of Surgical Research|April 12, 2025
Patient Characteristics and Outcomes in Clinically Misdiagnosed Patients With Merkel Cell CarcinomaYingjoy Li, Tu Tran, Bonnie A Lee, et al.
JAAD Case Reports|October 8, 2021
A case of acanthosis nigricans-like mycosis fungoidesDong Joo Kim, Sam Van Truong, Aimee Paik, et al.
JAAD Case Reports|June 24, 2026
COVID-19-associated cutaneous vasculitis with exfoliative erythroderma and extensive scarring: Long-term clinical and laser managementBritney T Nguyen, Xiying Fan, Kenneth G Linden, et al.
Clinical Immunology (Orlando, Fla.)|April 20, 2004
Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasisAlice B Gottlieb, Sewon Kang, Kenneth G Linden, et al.
Journal of the American Academy of Dermatology|June 5, 2019
Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic reviewFranchesca D Choi, Christina N Kraus, Ashley N Elsensohn, et al.
Journal of the American Academy of Dermatology|September 18, 2025
Rethinking radiation for resected pleomorphic dermal sarcoma: A National Cancer Database analysisYingjoy Li, Sarah W Yuen, Kenneth G Linden, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skinPhilip M Carpenter, Kenneth G Linden, Christine E McLaren, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
JAAD Case Reports|October 21, 2024
Relapsing toxic epidermal necrolysis following COVID-19Feben Messele, Luke Horton, Ajay N Sharma, et al.
International Journal of Dermatology|February 21, 2022
Yellow urticaria: a rare phenomenonSamuel A Stetkevich, Brittany Urso, Lina Saeed, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 28, 2010
Medical students educate teens about skin cancer: what have we learned?Jeanette M Kamell, William Rietkerk, Ken Lam, et al.
The Journal of Surgical Research|April 12, 2025
Patient Characteristics and Outcomes in Clinically Misdiagnosed Patients With Merkel Cell CarcinomaYingjoy Li, Tu Tran, Bonnie A Lee, et al.
JAAD Case Reports|October 8, 2021
A case of acanthosis nigricans-like mycosis fungoidesDong Joo Kim, Sam Van Truong, Aimee Paik, et al.
JAAD Case Reports|June 24, 2026
COVID-19-associated cutaneous vasculitis with exfoliative erythroderma and extensive scarring: Long-term clinical and laser managementBritney T Nguyen, Xiying Fan, Kenneth G Linden, et al.
Clinical Immunology (Orlando, Fla.)|April 20, 2004
Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasisAlice B Gottlieb, Sewon Kang, Kenneth G Linden, et al.
Journal of the American Academy of Dermatology|June 5, 2019
Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic reviewFranchesca D Choi, Christina N Kraus, Ashley N Elsensohn, et al.
Journal of the American Academy of Dermatology|September 18, 2025
Rethinking radiation for resected pleomorphic dermal sarcoma: A National Cancer Database analysisYingjoy Li, Sarah W Yuen, Kenneth G Linden, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skinPhilip M Carpenter, Kenneth G Linden, Christine E McLaren, et al.
Pageof 4